Predict your next investment

AFT Pharmaceuticals company logo
HEALTHCARE | Pharmaceuticals / Drugs
aftpharm.com

See what CB Insights has to offer

Business Relationships

2

AFT Pharmaceuticals Partners & Customers

2 Partners and customers

AFT Pharmaceuticals has 2 strategic partners and customers. AFT Pharmaceuticals recently partnered with Timber Pharmaceuticals on March 3, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

3/17/2021

Licensor

Timber Pharmaceuticals

United States

Timber Pharmaceuticals' Development Partner, AFT Pharmaceuticals, Enters Into Licensing Agreement For Pascomer® (TMB-002) In Europe

Basking Ridge , N.J. , March 17 , 2021 -- via NewMediaWire -- Timber Pharmaceuticals , Inc. , a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases , today announced that its development partner , AFT Pharmaceuticals Limited , has signed an exclusive license and supply agreement with Desitin Arzneimittel GmbH for Pascomer ® for the treatment of facial angiofibromas associated with Tuberous Sclerosis Complex in Europe .

1

3/20/2017

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

3/17/2021

3/20/2017

Type

Licensor

Partner

Business Partner

Timber Pharmaceuticals

Country

United States

Subscribe to see more

News Snippet

Timber Pharmaceuticals' Development Partner, AFT Pharmaceuticals, Enters Into Licensing Agreement For Pascomer® (TMB-002) In Europe

Basking Ridge , N.J. , March 17 , 2021 -- via NewMediaWire -- Timber Pharmaceuticals , Inc. , a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases , today announced that its development partner , AFT Pharmaceuticals Limited , has signed an exclusive license and supply agreement with Desitin Arzneimittel GmbH for Pascomer ® for the treatment of facial angiofibromas associated with Tuberous Sclerosis Complex in Europe .

Subscribe to see more

Subscribe to see more

Sources

1

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.